Skip to search formSkip to main contentSkip to account menu

pentazirinocyclodiphosphathiazene

Known as: pentakis(aziridino)thiatriazadiphosphorine oxide, 1,3,3,5,5-pentazridino-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide, 1H-1,2,4,6,3,5-Thiatriazadiphosphorine, 1,3,3,5,5-pentakis(1-aziridinyl)-3,3,5,5-tetrahydro-, 1-oxide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This paper computes the irreducible characters of the alternating Hecke algebras, which are deformations of the group algebras of… 
1986
1986
One important facet of flow cytometry involves the effects of pharmacological agents on cell cycle progression. Comparative G2… 
1985
1985
The treatment of HeLa and HL-60 cells with various concentrations of pentakis(arizidino)thiatriazadiphosphorine oxide results in… 
1984
1984
The B----Z conformational transition of double-stranded poly(dG-dC) induced by various nickel salts (chloride, sulfate… 
1984
1984
Experimental chemotherapies for 15 human cancers xenografted into nude mice were performed using 14 anticancer agents including 6… 
1982
1982
1,3,3,5,5-Pentaziridino-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide (SOAz), a new antitumor agent, was evaluated for antitumor… 
1982
1982
SOAz, an inorganic cyclic derivative, was given as a single iv injection through one cycle in a phase I trial. Dose-limiting…